Commit To Buy Intra-Cellular Therapies At $55, Earn 18.6% Annualized Using Options
Investors eyeing a purchase of Intra-Cellular Therapies Inc (Symbol: ITCI) shares, but tentative about paying the going market price of $62.88/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-80864706-af4bc38e94e34052a5106e15bf44b2a2.jpg "Benchmark Oils: Brent Crude, WTI, and Dubai")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-77294443-88c7023010c9410c933c8029b3931c91.jpg "Reasons to Avoid Long-Term Auto Loans")